Adenoviral vector transduction of the human deoxycytidine kinase gene enhances the cytotoxic and radiosensitizing effect of gemcitabine on experimental gliomas

Cancer Gene Therapy
T SzatmáriK Lumniczky

Abstract

The aim of this work was to improve the cytotoxic and radiosensitizing effects of gemcitabine using a gene-directed enzyme prodrug therapy approach. Murine Gl261, rat C6 and human U373 glioma cell lines were transduced with an adenoviral vector encoding the human deoxycytidine kinase gene (Ad-HudCK). Intracranial tumors were established in C57BL/6 mice and Wistar rats using either wild-type or Ad-HudCK-transduced Gl261 and C6 glioma cells. In vitro growing cells and established tumors were treated with gemcitabine and irradiation either alone or in combination. Deoxycytidine kinase overexpression substantially increased both the toxic and radiosensitizing effects of gemcitabine in each cell line, but the enhancement rate varied: it was mild in the Gl261 cells and much stronger in the C6 and U373 cells. In vivo experiments showed a mild radiosensitizing effect of dCK overexpression both in the Gl261 and C6 models. The combination of dCK overexpression, gemcitabine treatment and irradiation improved the survival rate of C6 bearing rats significantly. In conclusion, overexpression of the dCK gene can improve the cytotoxic and radiosensitizing effect of gemcitabine both in vitro and in vivo in a tumor-specific manner.

References

Aug 17, 1993·Biochemical Pharmacology·V W Ruiz van HaperenG J Peters
Mar 1, 1996·International Journal of Radiation Oncology, Biology, Physics·T S LawrenceD S Shewach
Jan 15, 1997·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Y F Hui, J Reitz
Nov 7, 1998·The Journal of Biological Chemistry·P HatzisI Talianidis
May 16, 2000·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S Z GertlerL Seymour
Oct 6, 2001·Biochemical and Biophysical Research Communications·A SandaA Karlsson
Jun 11, 2002·Biochemical and Biophysical Research Communications·Christian M BeauséjourRichard L Momparler
Jul 27, 2002·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Vincent GrégoirePierre Scalliet
Aug 17, 2002·International Journal of Radiation Oncology, Biology, Physics·Chris van BreeJaap Haveman
Jun 17, 2003·Nature Structural Biology·Elisabetta SabiniArnon Lavie
Oct 1, 1955·Proceedings of the Society for Experimental Biology and Medicine·F WROBLEWSKI, J S LADUE
Mar 24, 2004·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Jean-François RosierVincent Grégoire
Feb 9, 2005·Brain Tumor Pathology·Nobuyuki IrieIzumi Nagata
Jan 18, 2006·International Journal of Radiation Oncology, Biology, Physics·Michael R HorsmanJolyon H Hendry
Jun 27, 2006·Pathology Oncology Research : POR·Katalin Lumniczky, Géza Sáfrány
Sep 27, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·Fabienne VernejoulGérard Tiraby

❮ Previous
Next ❯

Citations

Apr 6, 2011·Breast Cancer Research and Treatment·Ernst-Jan GeutjesRené Bernards
Jan 1, 1990·Toxicon : Official Journal of the International Society on Toxinology·E PapiniC Montecucco
Jun 11, 2015·Journal of Genetics and Genomics = Yi Chuan Xue Bao·Louise Slot ChristiansenWolfgang Knecht
Nov 24, 2016·International Journal of Molecular Sciences·Rui ZhongXiaodong Liu

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.